Current NDC auxiliary source row compounder:4791

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 80098-030
Product Ndc: 80098-030
Product Ndc Digits: 80098030
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Isosulfan Blue
Proprietary Name Suffix: [empty]
Nonproprietary Name: ISOSULFAN BLUE
Dosage Form Name: INJECTION
Route Name: SUBCUTANEOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: STASKA PHARMACEUTICALS, INC.
Establishment Name: STASKA PHARMACEUTICALS, INC.
Establishment Fei: [empty]
Substance Name: ISOSULFAN BLUE
Active Ingredients Info: 10 mg/1 mL
History Active Ingredients Raw: ISOSULFAN BLUE
History Active Ingredients Info Raw: 10 mg/1 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 80098-030-90
Package Ndc: 80098-030-90
Package Ndc Digits: 8009803090
Package Ndc11: 80098003090
Package Description: 5 SYRINGE in 1 TRAY (80098-030-90) > 1 mL in 1 SYRINGE (80098-030-01)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:4791
Source Row Number: 4791
Source Row Hash: bdd6e7d75ffef95c243bbff8edf9a1f84ac129ee960169cea919464ea81ebef1
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "SUBCUTANEOUS",
    "PRODUCTNDC": "80098-030",
    "DEASCHEDULE": "",
    "LABELERNAME": "STASKA PHARMACEUTICALS, INC.",
    "SUBSTANCENAME": "ISOSULFAN BLUE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "80098-030-90",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Isosulfan Blue",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "ISOSULFAN BLUE",
    "PACKAGEDESCRIPTION": "5 SYRINGE in 1 TRAY (80098-030-90)  > 1 mL in 1 SYRINGE (80098-030-01) ",
    "ACTIVEINGREDIENTSINFO": "10 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:4791
Source Row Number: 4791
Status Scope: package
Lookup Ndc: 80098-030-90
Lookup Ndc Digits: 8009803090
Product Ndc: 80098-030
Product Ndc Digits: 80098030
Package Ndc: 80098-030-90
Package Ndc Digits: 8009803090
Package Ndc11: 80098003090
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: bdd6e7d75ffef95c243bbff8edf9a1f84ac129ee960169cea919464ea81ebef1
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33